Severe to profound deafness Ear, Nose and Throat Hearing loss, unspecified
Conditions
Interventions
The following procedures that are part of the remote monitoring test battery will be conducted with the patient using a cochlear implant just before they see the clinician or their standard appointmen
Sponsors
Cochlear Ltd (Australia)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Adults (>18 years) using cochlear implants or children (>4 years) using cochlear implants 2. Implanted with the CI500 series, CI24RE, Nucleus 24 Series or CI422 cochlear implants 3. User of commercially available CP900 series sound processor 4. At least 3 months experience with the cochlear implant 5. Ability to complete closed set speech perception of numbers 0 to 9 in the language used for the Digit Triplet Test (English) 6. Willingness to participate in and to comply with all requirements of the protocol 7. Routine clinical appointment scheduled during the study period
Exclusion criteria
Exclusion criteria: 1. Adults or parents/carers with limited English that would prevent completion of questionnaires 2. Nucleus 22 cochlear implant recipients 3. Additional handicaps that would prevent participation in evaluations 4. Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Whether the test battery provides sufficient information for the clinician to determine if the recipient needs any intervention, assessed through the Clinician Questionnaire at the single study visit | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoint The acceptance of the concept of remote monitoring for recipients or parent/carers, assessed through the Recipient/Parent Questionnaire at the single study visit Exploratory endpoint Feedback from clinicians regarding any additional clinical metrics that will increase the acceptability of the test battery for remote monitoring captured; collected at the single study visit | — |
Countries
England, Scotland, United Kingdom
Contacts
Public ContactHelen Cullington
Outcome results
None listed